CHESTERFIELD COUNTY, Va. (WRIC) — In recognition of Men’s Health Month, the University of Virginia (UVA) Cancer Center is expanding its “Stay in the Game” program, a vital community-centered ...

Black men face a higher risk of developing prostate cancer and often experience more aggressive forms of the disease. The journey through prostate cancer can be a daunting one, but it is not one that ...

ANN ARBOR, Michigan — Prostate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to stick to their prescription drug therapy than patients at ...

LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) announced the recipients of its 2024 Challenge Awards, funding over $16 million in innovative prostate cancer research for ...

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary ...

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...

MILWAUKEE - A Milwaukee program is focusing on helping Black prostate cancer survivors successfully recover. All men are at risk for prostate cancer, according to the CDC. However, African-American ...

Ernie Strauss and Ron Wakefield didn’t plan to become advocates. But after surviving prostate cancer, they can’t stay silent. One delayed having a physical for more than a decade. The other caught his ...

orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...

In early February, Fred Hutch began treating patients with ocular melanoma who've been recommended for proton therapy with a sophisticated new technique known as “pencil beam scanning” or PBS. Medical ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.